Director, Global GCP QA

Structure Therapeutics develops life‐changing medicines for patients using advanced structure‐based and computational drug discovery technology. The company’s platform combines the latest advancements in visualization of molecular interactions, computational chemistry, and data integration to design orally available, superior small molecule medicines that overcome current limitations of biologic and peptide drugs. We are advancing a clinical‐stage pipeline of differentiated treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic, and pulmonary conditions.

Structure Therapeutics is led by an experienced group of international drug innovators and financed by top-tier global life sciences investors. The company completed an initial public offering (IPO) in February 2023. With offices in California and Shanghai, Structure Therapeutics has the benefit of being at the center of life science innovation in both the US and China and capitalizing on the strengths of each geographic location.

The Director, Global GCP QA is responsible for governance, compliance oversight, and supporting strategic execution across clinical studies and vendor programs, in compliance with applicable national and international standards, regulations, and guidelines. The position will provide support and promote collaboration internally to ensure all systems; processes, and their outcomes remain compliant. The role will provide expert GCP guidance across global regulatory requirements (FDA, EMA, MHRA, NMPA, PMDA, etc.) and ensure compliance with ICH GCP, FDA, EMA, and other relevant global regulations. The role will collaborate cross-functionally to drive continuous improvement and ensure patient safety and data integrity. This position will report to the Executive Director, Global GCP, QA.

• Act as the primary GCP QA subject matter expert and point of contact for all GCP related matters and issues for the assigned early and late phase clinical and China clinical programs.
• Ensure ongoing clinical phase and China clinical programs are in compliance with applicable health authority regulations and guidelines.
• Provide quality oversight and review of key clinical and regulatory submission (e.g. IND/NDA) documents.

• Own and implement the risk-based GCP audit and compliance strategy across the clinical portfolio.
• Establish GCP quality governance forums and provide periodic compliance reports to senior leadership.
• Lead the assessment and escalation of significant quality events, serious breaches, systemic trends, and critical and major CAPAs.

• Monitor adverse trends for the assigned studies. Create and manage issue trends and make recommendations to management.

• Provide strategic oversight of CROs and other critical clinical vendors.
• Manage or mentor GCP QA employees, consultants, and contracted auditors.
• Represent GCP QA in governance committees and major program decisions.

• Work with cross-functional teams to assess and manage risks associated with vendors, supporting study compliance, data integrity, and participant safety.
• Perform reviews of clinical trial documentation for data integrity and compliance with Good Clinical Practice guidance and regulations.
• Support the creation, maintenance, and improvement of quality SOPs, manuals, templates, process maps, and approval flows to establish a robust GCP QMS.

• Drive the implementation of continuous improvement initiatives across Global QA processes to enhance operational efficiency and maintain high compliance standards.

• Partner with clinical functions to provide quality guidance and drive the implementation of fit-for-purpose procedures that ensure data and documentation are generated and managed in compliance with GCP.
• Promote a culture of quality through effective communication, training, and proactive engagement with internal and external stakeholders.
• Lead periodic reporting of key quality metrics to leadership to support continuous improvement in GCP compliance across Structure.

• Develop strategies and execute/lead audits for the assigned studies, including internal processes, investigator sites, vendors/CROs, TMFs, and CSRs (both routine and for-cause).
• Approve audit findings and reports, ensure effective root cause analysis and action plans and approve audit CAPAs.
• Lead and oversee GCP-related vendor qualification and oversight, ensuring adherence to global quality standards, contracts and quality agreements.
• Evaluate and mitigate compliance risks in GCP domain with a focus on risk-based thinking and operational efficiency.

• Lead sponsor inspection readiness and regulatory inspection activities, including inspection strategy, front-room/back-room execution, and response development.

• Support global regulatory authority inspections and lead/support site and vendor inspection readiness.
• Maintain a contemporary knowledge of current agency and industry trends, standards, and methodologies related to GCPs.

• BS/MS or equivalent in a scientific discipline required; advanced degree is preferred.
• Auditor certifications and/or SQA RQAP credentials are preferred.

• 10+ years of pharmaceutical/biotechnology experience, including at least 7+ years in GCP QA lead auditor role.
• Prior experience in Big Pharma is preferred.

• Proven leadership in supporting regulatory inspections (FDA, EMA, MHRA, NMPA, PMDA).
• Expertise in ICH E6, E8, E2A-F, 21 CFR Part 11, EU Annex 11, and other global standards.
• Prior success in designing and executing QMS systems, including vendor management and system implementation.
• Working knowledge of EDMS and other document and data management platforms.
• MUST HAVE: GCP QA experience

• Highly organized and detail-oriented, with the ability to manage multiple priorities in a fast-paced, evolving environment.
• Exceptional leadership, project management, and communication skills.
• Bias for action with the ability to drive outcomes across matrixed teams and third parties.
• Strong strategic thinking and adaptability in a fast-paced, global environment.

Travel Required:Up to 50% depending on location. Role can be REMOTE or ONSITE (if onsite, hybrid model).

Structure Therapeutics Inc. is an Equal-Opportunity Employer.

Structure Therapeutics is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are market competitive. For this role, the anticipated base pay range is $185,000-$250,000. The exact base pay offered for this role will depend on various factors, including but not limited to the candidate’s geography, qualifications, skills, and experience.

At Structure, base pay is only one part of your total compensation package. The successful candidate will be eligible for an annual performance incentive bonus, new hire equity, and ongoing performance-based equity. Structure Therapeutics also offers various benefits offerings, including, but not limited to, medical, dental, and vision insurance, 401k match, unlimited PTO, and a number of paid holidays including winter shutdown.

Recruiters and staffing agencies should not contact Structure Therapeutics through this page. All recruitment vendors (search firms, recruitment agencies, and staffing companies) are prohibited from contacting our hiring manager(s), executive team members, or employees.

We require that all recruiters and staffing agencies have a fully executed, formal written agreement on file.

Structure Therapeutics’ receipt or acceptance of an unsolicited resume submitted by a vendor organization to this website or employee does not constitute an actual or implied contract between Structure Therapeutics and such organization and will be considered unsolicited and Structure Therapeutics will not be responsible for related fees.

To all candidates: your personal information and online safety are a top priority for us. At Structure Therapeutics, direct candidates to apply through our official career page at BambooHR.

Recruiters will always contact you using the domain of Structuretx.com. We will never request payments, ask for financial account information or sensitive information like social security numbers. If you are unsure if a message is from Structure Therapeutics, please email human resources at

Originally posted on Himalayas